Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-19 4:27 pm Purchase | 2021-02-10 | 13G | Mereo BioPharma Group plc MREO | SUVRETTA CAPITAL MANAGEMENT LLC | 31,827,500 5.900% | 31,827,500 (New Position) | Filing History |
| 2021-02-16 4:53 pm Purchase | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Baker Bros. Advisors LP | 39,631,929 11.400% | 39,631,929 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX, LLC | 8,960,296 8.168% | -21,635,328 (-70.71%) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Citadel Advisors LLC | 30,930,386 8.900% | -202,605 (-0.65%) | Filing History |
| 2021-02-16 4:29 pm Sale | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Boxer Capital LLC | 10,309,250 9.100% | -10,052,625 (-49.37%) | Filing History |
| 2021-02-12 5:00 pm Purchase | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | ORBIMED ADVISORS LLC | 4,518,356 6.660% | 4,518,356 (New Position) | Filing History |